CONTRA NEOLEUKIN THERA Neoleukin Therapeutics, Inc.

CONTRA NEOLEUKIN THERA Neoleukin Therapeutics, Inc. is a security (CUSIP 640CVR031) tracked across SEC portfolio filings. 1 registered fund positions totaling n/a via N-PORT as of 2026-04-30.

Summary

• Issuer: CONTRA NEOLEUKIN THERA
• Class: Neoleukin Therapeutics, Inc.
• CUSIP: 640CVR031
• Asset category: DE
• 13F holders: 0
• N-PORT fund positions: 1
• N-PORT report: 2026-04-30

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search